TGS


Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors

Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors

https://www.gov.uk/government/news/concizumab-approved-to-prevent-or-reduce-the-frequency-of-bleeding-episodes-in-people-aged-12-years-and-older-with-haemophilia-a-or-b-with-inhibitors

seen at 14:51, 24 October in News and communications.